This Biotech Stock 135% Jump Trims $44M: What Now Today
A biotech stock that surged 135% in a year suddenly sees a big investor trim its stake by about $44 million. Here’s h...
This guide weighs the advantages and drawbacks of target date versus lifecycle funds to help you pick the option that best fits your retirement plan.
25,428 articlesA biotech stock that surged 135% in a year suddenly sees a big investor trim its stake by about $44 million. Here’s h...
The passing of a long-time CEO marks a watershed moment for any company. This guide helps investors evaluate Simon Pr...
Ford stock keeps going as investors bet on EV momentum and steady cash flow. This guide breaks down the factors fueli...
Maze Therapeutics stock still faces mixed signals from the market: a strong rally after a March dip, paired with a no...
As Kolibri wraps its Q4 2025 results, investors seek clarity on growth, margins, and cash flow. This article translat...
A sharp bond selloff has investors seeking guidance on where invest bonds right. This report outlines a practical app...
The Las Vegas Strip bid farewell to a family-driven dining concept after almost four years. This article breaks down ...
Markets react as new policy steps linked to Social Security raise questions about the accuracy of past pledges. Inves...
Major brokerages issued new research on top names like Airbnb, Broadcom, Chipotle, and NVIDIA as investors rotate str...
U.S. stocks climbed as data suggested resilience in growth and jobs. Analysts weigh whether the economy really perfor...
CNM's first-quarter numbers set the stage for the year ahead. This guide breaks down what the earnings mean for inves...
A widening split on who can afford a home is reshaping the housing landscape. This article breaks down why the divide...